Comparison of baseline clinical characteristics among people with type 2 diabetes on second-line therapy previously added with dapagliflozin or another oral glucose-lowering drug: AGORA study Vicente Pallarés-Carratalá; Antonio Ruiz-García; Adalberto Serrano-Cumplido; Antonio Segura Fragoso; Verónica Fernández-Pascual; Beatriz Sánchez-Sánchez; María Inmaculada Cervera-Pérez; Francisco Javier Alonso-Moreno; Ezequiel Arranz-Martínez; Alfonso Barquilla-García; Daniel Rey-Aldana; José Polo García; Sergio Cinza-Sanjurjo;

Oxidative stress and inflammation link Life's Essential 8 with adverse cardiovascular events in adults with diabetes mellitus: NHANES 2011¿2018 Ronghao Li; Mengfan Li; Xinyi Wang; Zhongyun Zhou;

Increasing muscular strength to improve cardiometabolic risk factors Patricio Lopez-Jaramillo; Jose P. Lopez-Lopez; Maria Camila Tole; Daniel D. Cohen;